By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > MTUM: Lacks Momentum Much Of The Time (BATS:MTUM)
News

MTUM: Lacks Momentum Much Of The Time (BATS:MTUM)

News
Last updated: 2023/06/07 at 2:38 AM
By News
Share
7 Min Read
SHARE

Momentum is like a rocket ship. Be careful it doesn’t come back down on you.

Contents
Momentum FactorsFactor DecayReconstructing the MTUM StrategySummary

Momentum is one of the most well-studied premiums in academic literature. The basic concept is this: what out-performs continues to out-perform.

So why are we reluctant to recommend the iShares MSCI USA Momentum Factor ETF (BATS:MTUM)? It boils down to one reason – factor decay.

But before we explain that concept, let’s have a general overview of MTUM and how it is constructed.

Momentum Factors

There are numerous ways to design a momentum filter. The most basic approach is to look for stocks with the highest trailing performance over the past 3, 6, 9 or 12 months. Many practitioners will also remove the most recent month’s performance since short-term returns tend to be contrarian signals and work directly against momentum. What does this mean?

  • A stock which steadily goes up 100% in a year may have momentum which means more upwards price action.
  • A stock which is flat all year but then goes up 100% in one month is likely to go down short-term.

MTUM uses a different approach than what is described above and which is exceedingly close to a modified Sharpe Ratio. While they use the 6-month and 12-month trailing price performance, they divide this by the annualized standard deviation of weekly returns from the past 3 years. Come again?

To illustrate, suppose we have two stocks.

  • Stock A went up 100%
  • Stock B went up 50%

Traditional momentum measures would have us buying stock A. But what is the average volatility of those stocks? Suppose stock A had annualized volatility of 40% while stock B had annualized volatility of 17%. With this we can compute the custom momentum score.

  • Stock A has a momentum score of 100 / 40 = 2.5
  • Stock B has a momentum score of 50 / 17 = 2.94

In this scenario, stock B had a higher risk-adjusted momentum score even though the returns of stock A were higher. Like I said earlier, it is basically a modified Sharpe Ratio of returns over volatility. There is a little more to it than that – but this is the main thrust of the fund.

I don’t consider their approach to momentum to be good or bad – just note the difference of how they determine momentum from the classical definition.

Factor Decay

But the real reason why I don’t recommend buying MTUM is due to factor decay. What is factor decay? This refers to the length of time it takes for a stock to lose its properties. What is momentum today might not be momentum in a year from now. The properties of a stock change over time.

A recent paper looked into how fast factor information decays on a global scale. They considered the factor styles of value, quality, low volatility, investment, and momentum. What they found is that momentum has the fastest decay.

  • The optimal rebalance for the momentum factor? 3 months
  • The rebalance frequency of MTUM? 6 months

This means that depending on when you purchase MTUM, you may not be investing in the momentum premium at all.

Let’s test this.

Reconstructing the MTUM Strategy

Using the tools at Portfolio123.com I recreated MTUM’s momentum ranking system. Because this fund invests in mid-cap to large-cap stocks I will use the Russell 1000 as my base universe.

Next, I go to the iShares website and I look up what the holdings were as of December. I import those into Portfolio123 and analyze the average momentum ranking as of December 1st compared to the Russell 1000 index. It is no surprise that the average rank is over 87 out of 100.

Just remember that a momentum rank of 50 is neutral and means there is no momentum at all. A rank above 50 means positive momentum and a rank below 50 is negative momentum.

Let’s fast-forward to the end of May 2023 when we are due for our next rebalance. The average rank has now fallen to 57 out of 100.

To illustrate, look at CVS. The 6 month chart will show the momentum ranking (green dotted line) and the price of CVS (red line). What started as very high momentum soon crashed.

CVS has falling momentum over the 6 month holding period

CVS Momentum Ranks (portfolio123.com)

This makes me think about NVDA’s rapid climb and high momentum. Will the recent purchase of NVDA favor the momentum premium or might it revert back down to some longer-term average? MTUM will re-examine this in another 6 months which seems far too long in my opinion.

NVDA has high momentum at time of rebalance

NVDA Rising Momentum (portfolio123.com)

This final chart shows you the equal-weight average momentum score of MTUM between rebalance points. The ETF went from moderately high momentum to almost being completely momentum neutral.

MTUM factor decay over time

MTUM Momentum Score (Portfolio123.com)

Summary

MTUM is a momentum factor tilt fund with one major flaw – it rebalances too infrequently. Due to factor decay, MTUM should rebalance every 3 months to keep the fund well placed in the middle of the momentum premium. As such, we recommend holding MTUM only for the first few months following rebalance. After that, it really isn’t a great momentum fund until the start of the next rebalance.

Read the full article here

News June 7, 2023 June 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

‘Good’ Jobs Data Occludes Weak Private Sector Hiring, 50% Are State/Local Employees

By News
News

Live Oak Bancshares: Earnings Outlook Is Positive, But Stock Seems Overvalued (NYSE:LOB)

By News
News

Thermo Fisher: A Quantitative Deep Dive Reveals Value But No Clear Uptrend

By News
News

Franklin Covey Co. (FC) Q3 2025 Earnings Call Transcript

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?